Conventional insulin pump therapy in two neonatal diabetes patients harboring the homozygous PTF1A enhancer mutation: Need for a novel approach for the management of neonatal diabetes.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Turkish Journal of Pediatrics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.24953/turkjped.2017.04.013PMID 29624227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Successful Treatment of a Very Low-Birth-Weight Infant With GATA6 Neonatal Diabetes Using Continuous Subcutaneous Insulin Infusion

  2025cites this paper
• International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Insulin and Adjunctive Treatments in Children and Adolescents with Diabetes

  2025cites this paper
• Insulin Delivery Technology for Treatment of Infants with Neonatal Diabetes Mellitus: A Systematic Review

  2024cites this paper
• Isolated Pancreatic Agenesis Secondary to PTF1A Gene Mutation: A Case Series and Literature Review

  2023cites this paper
• Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease

  2023cites this paper
• ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes

  2022cites this paper
• Transient Neonatal Diabetes Mellitus Managed with Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring

  2021cites this paper
• Clinical Characteristics and Long-term Follow-up of Patients with Diabetes Due To PTF1A Enhancer Mutations

  2020influential citation